We hypothesized that this analysis would enhance the knowledge about Nectin-2 and Nectin-4 regarding their potential function as novel biomarkers associated with tumor aggressiveness and metastatic potential in LSCC, contributing to risk stratification and therapeutic decision-making. Here, NECTIN4 is linked to neoplasm.